Among the many lessons learned throughout my career one that stands out is the idea of truly creating value for our clients. It’s not about how many hours you put in or getting from point A to point B – it’s about helping our clients realize the value they've worked a lifetime to build. When our professional process and knowledge are applied to enhance that value they created, it’s incredibly satisfying and rewarding.


John Kerschen

President and Managing Partner

John Kerschen has more than 30 years of financial experience in commercial banking, merger and acquisition advisory, and private capital investment. Since joining Charter Capital Partners in 1996, he has been responsible for more than 200 acquisition transactions with aggregate value of more than $2 billion. These transactions include diverse industries, such as manufacturing of metal parts, plastics, electronics, and medical products, as well as construction services, energy services, business services, and various distribution industries. John’s significant banking and financial background combined with his strong transaction management skills have been instrumental to Charter’s success over the years.

John is general partner and actively manages various investment funds including Charter Growth Capital Fund, a mezzanine debt and minority equity fund, Michigan Accelerator Fund I, an early stage VC fund as well as multiple other private equity investment entities.

He is a current board member for Keystone Solutions, Rim Guard, Ablative Solutions and Hastings Mutual Insurance Company and a board observer for Trice Medical and Swift Biosciences. John is a past board member for Grand River Aseptic Manufacturing, Intervention Insights, the Michigan Medical Device Accelerator and the national board for the Association for Corporate Growth.


  • BA, Michigan State University
  • MBA, DePaul University


  • FINRA securities registrations Series 79, 62, 63 and 65
  • Certified Valuation Analyst designation from the National Association of Certified Valuations and Analysts


Featured Transactions


  • This field is for validation purposes and should be left unchanged.
Scroll to Top